WebSep 26, 2024 · An increase in hepatic vascular resistance to portal blood flow is the main factor of intrahepatic PH. The structural component contributing about 70% to the intrahepatic vascular resistance is caused by the disturbed liver architecture, fibrotic tissue, regenerative nodules, angiogenesis, narrowing of intrahepatic blood vessels by … WebApr 27, 2024 · Portal hypertension is a major complication of cirrhosis characterized by a pathological hepatic venous pressure gradient (HVPG) ≥ 5 mmHg. The structural …
Telemedicine in Obstetrics: Quality and Wellbeing Contemplations
WebNov 24, 2024 · Abstract: Progressive familial intrahepatic cholestasis (PFIC) is a group of autosomal recessive cholestatic liver diseases which are subgrouped according to the genetic defect, clinical presentation, laboratory findings and liver histology. Progressive liver fibrosis, cirrhosis, and end stage liver disease (ESLD) may eventually develop. WebAbstract Background Intrahepatic cholangiocarcinoma (iCCA) is a highly aggressive cancer that is challenging to diagnose at an early stage. Despite recent advances in combination chemotherapy, drug resistance limits the therapeutic value of this regimen. iCCA reportedly harbors high HMGA1 expression and pathway alterations, especially hyperactivation of … bart55
Ascites, refractory ascites and hyponatremia in cirrhosis - OUP …
WebJul 5, 2024 · Apart from cirrhosis, any cause of increased resistance to hepatic or portal venous flow can lead to ascites. There is an increase in intrahepatic resistance, causing increased portal pressure. This increased pressure within the hepatic veins or post sinusoidal level increases hydrostatic pressure within the hepatic sinusoids and portal veins. WebNov 29, 2024 · The hyperdynamic circulation is triggered by increased intrahepatic resistance due to cirrhosis, leading to a progressive increase in portal venous pressure [7, 8]. As portal hypertension worsens, there is an increased local production of vasodilators due to endothelial activation, leading to splanchnic and systemic arterial vasodilation. WebApr 7, 2024 · Introduction. Cholangiocarcinoma (CCA), the second most common primary liver tumor after hepatocarcinoma, has rare therapeutic options and a high mortality rate. 1 It can be divided into intrahepatic, perihilar, and distal CCA. Surgical resection and liver transplant are the potential treatment options in the early stages of CCA; however, early … sva binaire